PhiloGene, Inc. Announces that VEGFb(TM) has been Granted Orphan Drug Designation by the FDA for
... VEGFb. "This is a significant milestone and accomplishment for PhiloGene," commented Miriam Mangelus, PhD MBA, CEO of PhiloGene. "We are very pleased to receive this support from the FDA, ...